To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Oral non-steroidal anti-inflammatory drugs: viable for pain relief of RC tendinopathy

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
May 2014

Oral non-steroidal anti-inflammatory drugs: viable for pain relief of RC tendinopathy

Vol: 3| Issue: 5| Number:41| ISSN#: 2564-2537
Study Type:Meta-analysis/Systematic Review
OE Level Evidence:2
Journal Level of Evidence:N/A

The efficacy of oral non-steroidal anti-inflammatory drugs for rotator cuff tendinopathy: A systematic review and meta-analysis.

J Rehabil Med. 2014 Mar 31;46(4):294-306. doi: 10.2340/16501977-1800.

Contributing Authors:
J Boudreault F Desmeules JS Roy C Dionne P Frémont JC Macdermid

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

12 randomized control trials comparing oral non-steroidal anti-inflammatory drugs (NSAIDs) to any another intervention for adult patients with rotator cuff tendinopathy were included in this systematic review/meta-analysis. Upon analysis, low to moderate grade evidence supports the use of oral non-steroidal anti-inflammatory drugs (NSAIDs) for short-term pain relief compared to placebo. In additio...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue